Free Trial

Afya (NASDAQ:AFYA) Rating Increased to Strong-Buy at Wall Street Zen

Afya logo with Consumer Discretionary background

Key Points

  • Afya's stock rating was upgraded from "buy" to a "strong-buy" by Wall Street Zen, reflecting increased investor confidence.
  • Analysts at Morgan Stanley set a $17.50 target price, while JPMorgan Chase increased their target from $23.50 to $24.50, indicating positive outlooks for the company.
  • Institutional investors and hedge funds hold approximately 88.02% of Afya's stock, showing strong institutional backing.
  • Five stocks to consider instead of Afya.

Afya (NASDAQ:AFYA - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report issued on Saturday.

A number of other equities research analysts have also weighed in on the stock. Citigroup raised shares of Afya from a "sell" rating to a "neutral" rating and lowered their price target for the company from $16.00 to $14.00 in a report on Tuesday, July 29th. JPMorgan Chase & Co. raised shares of Afya from a "neutral" rating to an "overweight" rating and raised their price target for the company from $23.50 to $24.50 in a report on Monday, September 8th. UBS Group raised shares of Afya from a "neutral" rating to a "buy" rating and lowered their price target for the company from $19.50 to $19.00 in a report on Monday, September 8th. Zacks Research raised shares of Afya to a "hold" rating in a report on Friday, August 8th. Finally, Morgan Stanley set a $17.50 price target on shares of Afya and gave the company an "overweight" rating in a report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Afya currently has a consensus rating of "Hold" and a consensus price target of $18.20.

Get Our Latest Analysis on AFYA

Afya Trading Up 0.1%

Shares of Afya stock traded up $0.02 during trading hours on Friday, hitting $15.96. The company's stock had a trading volume of 68,302 shares, compared to its average volume of 80,653. Afya has a 1-year low of $13.47 and a 1-year high of $19.90. The business has a fifty day moving average of $15.02 and a 200 day moving average of $16.96. The company has a market capitalization of $1.50 billion, a PE ratio of 12.09, a P/E/G ratio of 0.48 and a beta of 0.56. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.22.

Institutional Trading of Afya

Hedge funds have recently bought and sold shares of the company. Public Employees Retirement System of Ohio lifted its position in Afya by 40.0% in the 4th quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company's stock valued at $44,000 after purchasing an additional 800 shares during the last quarter. Militia Capital Partners LP bought a new stake in Afya in the 2nd quarter valued at about $71,000. Quantbot Technologies LP bought a new stake in Afya in the 2nd quarter valued at about $117,000. State of Wyoming bought a new stake in Afya in the 2nd quarter valued at about $164,000. Finally, Quadrature Capital Ltd bought a new stake in Afya in the 2nd quarter valued at about $181,000. 88.02% of the stock is currently owned by institutional investors.

Afya Company Profile

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Recommended Stories

Analyst Recommendations for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.